Skip to content
Open access

In-hospital and 1-year mortality after percutaneous coronary intervention in patients without standard modifiable risk factors: a mediation analysis from Thai PCI registry

Oct 2026 · European Heart Journal · 0 citations

Abstract

Standard modifiable risk factors (SMuRFs), including hypertension, hypercholesterolemia, diabetes, and smoking, contribute substantially to atherosclerosis. However, patients with SMuRF-less remain at risk of mortality after percutaneous coronary intervention (PCI). The mechanisms underlying this risk are not well understood. This study aimed to identify clinical pathways mediating short- and long-term mortality among SMuRF-less patients undergoing PCI. Data from a multicenter Thai PCI registry was used including patients who underwent PCI at 39 cardiac centers between 2018-2019. Patients with prior coronary artery syndromes were excluded. Clinical data, procedural characteristics, medication use during PCI and at discharge, and outcomes (in-hospital and 1-year-death) were collected. Mediation analyses were performed using generalized structural equation modeling to assess indirect effects of SMuRF-less on death through STEMI presentation, antiplatelet therapy, procedural complications, guideline-directed medical therapy (GDMT: RAAS, beta-blocker and statins). Among 12,190 eligible patients, 684 (5.6%) were SMuRF-less. In-hospital death was significantly higher in SMuRF-less than at-least-one SMuRF (5.6% vs 3.5%). After adjusting covariates, SMuRF-less was significantly higher odds of death [OR = 1.70 (95% CI: (1.31, 2.23)]. STEMI significantly mediated this association [indirect OR = 1.33 (1.20, 1.88)], whereas mediation through clopidogrel and procedural complication was minimal. Among hospital survivors, SMuRF-less was not significantly associated with 1-year death [OR= 0.96 (0.66, 1.25)]; however, lower use of RAAS blockade [OR = 1.29 (1.16, 1.45)], beta-blocker[OR=1.05 (1.01, 1.12)] and statins [OR = 1.38 (1.10, 1.76)] significantly mediated increased 1-year-death. Early mortality among SMuRF-less patients undergoing PCI is largely driven by STEMI presentation, whereas long-term risk is influence by underuse of secondary prevention therapies. Ensuring equitable GDMTs is essential to improving outcomes in this population.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.